Goldman Sachs raised the firm’s price target on Legence (LGN) to $46 from $37 and keeps a Buy rating on the shares. Legence jumped 21% after reporting strong Q3 results, with 26% organic growth and a 1.5x book-to-bill that supports expectations for continued double-digit growth in 2026, the analyst tells investors in a research note. The company also announced a $475M acquisition of The Bowers Group, boosting its data-center exposure and reinforcing investor confidence in both its sustained organic growth outlook and its ability to pursue value-enhancing M&A.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGN:
- Legence price target raised to $37 from $34 at Barclays
- Legence price target raised to $45 from $40 at BTIG
- Legence Corp. Receives Buy Rating Amid Strong Financial Performance and Strategic Growth Initiatives
- Legence Corp. Reports Strong Q3 2025 Results and Strategic Acquisitions
- Midday Fly By: Walmart names new CEO, Merck acquires Cidara